カテゴリ： 世界, 医療/バイオ, Market Monitor Global

関節用注射用ビスコサプリメントのグローバル市場展望 2023年-2029年：単回注射、3回注射、5回注射

■ 英語タイトル：Injectable Viscosupplementation for Joint Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8368）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8368
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[関節用注射用ビスコサプリメントのグローバル市場展望 2023年-2029年：単回注射、3回注射、5回注射]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の関節用注射用ビスコサプリメント市場規模と予測を収録しています。・世界の関節用注射用ビスコサプリメント市場：売上、2018年-2023年、2024年-2029年
・世界の関節用注射用ビスコサプリメント市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の関節用注射用ビスコサプリメント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単回注射」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

関節用注射用ビスコサプリメントのグローバル主要企業は、Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfengなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、関節用注射用ビスコサプリメントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の関節用注射用ビスコサプリメント市場：タイプ別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：タイプ別市場シェア、2022年
・単回注射、3回注射、5回注射

世界の関節用注射用ビスコサプリメント市場：用途別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の関節用注射用ビスコサプリメント市場：地域・国別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における関節用注射用ビスコサプリメントのグローバル売上、2018年-2023年
・主要企業における関節用注射用ビスコサプリメントのグローバル売上シェア、2022年
・主要企業における関節用注射用ビスコサプリメントのグローバル販売量、2018年-2023年
・主要企業における関節用注射用ビスコサプリメントのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng

*************************************************************

・調査・分析レポートの概要
関節用注射用ビスコサプリメント市場の定義
市場セグメント
世界の関節用注射用ビスコサプリメント市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の関節用注射用ビスコサプリメント市場規模
世界の関節用注射用ビスコサプリメント市場規模：2022年 VS 2029年
世界の関節用注射用ビスコサプリメント市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの関節用注射用ビスコサプリメントの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の関節用注射用ビスコサプリメント製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：単回注射、3回注射、5回注射
関節用注射用ビスコサプリメントのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
関節用注射用ビスコサプリメントの用途別グローバル売上・予測

・地域別市場分析
地域別関節用注射用ビスコサプリメント市場規模 2022年と2029年
地域別関節用注射用ビスコサプリメント売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng
...

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation for Joint, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation for Joint. This report contains market size and forecasts of Injectable Viscosupplementation for Joint in global, including the following market information:
Global Injectable Viscosupplementation for Joint Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Injectable Viscosupplementation for Joint Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Injectable Viscosupplementation for Joint companies in 2022 (%)
The global Injectable Viscosupplementation for Joint market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Viscosupplementation for Joint include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Viscosupplementation for Joint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Viscosupplementation for Joint Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Type, 2022 (%)
Single Injection
Three Injection
Five Injection
Global Injectable Viscosupplementation for Joint Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Injectable Viscosupplementation for Joint Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Viscosupplementation for Joint revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Viscosupplementation for Joint revenues share in global market, 2022 (%)
Key companies Injectable Viscosupplementation for Joint sales in global market, 2018-2023 (Estimated), (Units)
Key companies Injectable Viscosupplementation for Joint sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Viscosupplementation for Joint, market overview.
Chapter 2: Global Injectable Viscosupplementation for Joint market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Viscosupplementation for Joint manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Viscosupplementation for Joint in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Viscosupplementation for Joint capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Injectable Viscosupplementation for Joint Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Viscosupplementation for Joint Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Viscosupplementation for Joint Overall Market Size
2.1 Global Injectable Viscosupplementation for Joint Market Size: 2022 VS 2029
2.2 Global Injectable Viscosupplementation for Joint Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Injectable Viscosupplementation for Joint Sales: 2018-2029
3 Company Landscape
3.1 Top Injectable Viscosupplementation for Joint Players in Global Market
3.2 Top Global Injectable Viscosupplementation for Joint Companies Ranked by Revenue
3.3 Global Injectable Viscosupplementation for Joint Revenue by Companies
3.4 Global Injectable Viscosupplementation for Joint Sales by Companies
3.5 Global Injectable Viscosupplementation for Joint Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Injectable Viscosupplementation for Joint Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Injectable Viscosupplementation for Joint Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Players in Global Market
3.8.1 List of Global Tier 1 Injectable Viscosupplementation for Joint Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Injectable Viscosupplementation for Joint Market Size Markets, 2022 & 2029
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
4.2.1 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
4.2.2 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
4.2.3 By Type – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
4.3 By Type – Global Injectable Viscosupplementation for Joint Sales & Forecasts
4.3.1 By Type – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
4.3.2 By Type – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
4.3.3 By Type – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
4.4 By Type – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Injectable Viscosupplementation for Joint Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
5.2.1 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
5.2.2 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
5.2.3 By Application – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
5.3 By Application – Global Injectable Viscosupplementation for Joint Sales & Forecasts
5.3.1 By Application – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
5.3.2 By Application – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
5.3.3 By Application – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
5.4 By Application – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Injectable Viscosupplementation for Joint Market Size, 2022 & 2029
6.2 By Region – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
6.2.1 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
6.2.2 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
6.2.3 By Region – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
6.3 By Region – Global Injectable Viscosupplementation for Joint Sales & Forecasts
6.3.1 By Region – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
6.3.2 By Region – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
6.3.3 By Region – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.4.2 By Country – North America Injectable Viscosupplementation for Joint Sales, 2018-2029
6.4.3 US Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.4.4 Canada Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.4.5 Mexico Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.5.2 By Country – Europe Injectable Viscosupplementation for Joint Sales, 2018-2029
6.5.3 Germany Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.4 France Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.5 U.K. Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.6 Italy Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.7 Russia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.8 Nordic Countries Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.9 Benelux Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.6.2 By Region – Asia Injectable Viscosupplementation for Joint Sales, 2018-2029
6.6.3 China Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.4 Japan Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.5 South Korea Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.6 Southeast Asia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.7 India Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.7.2 By Country – South America Injectable Viscosupplementation for Joint Sales, 2018-2029
6.7.3 Brazil Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.7.4 Argentina Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Sales, 2018-2029
6.8.3 Turkey Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.4 Israel Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.5 Saudi Arabia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.6 UAE Injectable Viscosupplementation for Joint Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injectable Viscosupplementation for Joint Major Product Offerings
7.1.4 Sanofi Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Company Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Major Product Offerings
7.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.2.5 Anika Therapeutics Key News & Latest Developments
7.3 Seikagaku
7.3.1 Seikagaku Company Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Injectable Viscosupplementation for Joint Major Product Offerings
7.3.4 Seikagaku Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.3.5 Seikagaku Key News & Latest Developments
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Major Product Offerings
7.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.4.5 Zimmer Biomet Key News & Latest Developments
7.5 Bioventus
7.5.1 Bioventus Company Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Injectable Viscosupplementation for Joint Major Product Offerings
7.5.4 Bioventus Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.5.5 Bioventus Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Injectable Viscosupplementation for Joint Major Product Offerings
7.6.4 Ferring Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.6.5 Ferring Key News & Latest Developments
7.7 LG Chem
7.7.1 LG Chem Company Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Injectable Viscosupplementation for Joint Major Product Offerings
7.7.4 LG Chem Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.7.5 LG Chem Key News & Latest Developments
7.8 Freda
7.8.1 Freda Company Summary
7.8.2 Freda Business Overview
7.8.3 Freda Injectable Viscosupplementation for Joint Major Product Offerings
7.8.4 Freda Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.8.5 Freda Key News & Latest Developments
7.9 Haohai Biological
7.9.1 Haohai Biological Company Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Injectable Viscosupplementation for Joint Major Product Offerings
7.9.4 Haohai Biological Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.9.5 Haohai Biological Key News & Latest Developments
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Company Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Major Product Offerings
7.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai Jingfeng Key News & Latest Developments
8 Global Injectable Viscosupplementation for Joint Production Capacity, Analysis
8.1 Global Injectable Viscosupplementation for Joint Production Capacity, 2018-2029
8.2 Injectable Viscosupplementation for Joint Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Viscosupplementation for Joint Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Viscosupplementation for Joint Supply Chain Analysis
10.1 Injectable Viscosupplementation for Joint Industry Value Chain
10.2 Injectable Viscosupplementation for Joint Upstream Market
10.3 Injectable Viscosupplementation for Joint Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射用ビスコサプリメントのグローバル市場展望 2023年-2029年：単回注射、3回注射、5回注射
  • 医療用ヒアルロン酸粘液補充の世界市場2023年：単回注射、複数回注射
  • 注射用スマトリプタンのグローバル市場展望 2023年-2029年：4mg、6mg、その他
  • 脂質注射用エマルジョンのグローバル市場展望 2023年-2029年：濃度10%、濃度20%
  • 注射用薬物送達システムのグローバル市場展望 2023年-2029年：充填済み注射器、自動注射器（シリンジ式およびカートリッジ式）、ペン型注射器、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8368 )"関節用注射用ビスコサプリメントのグローバル市場展望 2023年-2029年：単回注射、3回注射、5回注射" (英文：Injectable Viscosupplementation for Joint Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。